NDC 70518-3423-07 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3423
- Requested NDC
- 70518-3423-07
- Package NDCs from labels
- 70518-3423-0, 70518-3423-1, 70518-3423-3, 70518-3423-2, 70518-3423-5, 70518-3423-4, 70518-3423-7, 70518-3423-6, 70518-3423-07
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam Tablets, USP C-IV | REMEDYREPACK INC. | 2026-08-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3423-0 | Lorazepam | 30 in 1 BLISTER PACK | TABLET | 30 | 8 | |
| 70518-3423-1 | Lorazepam | 30 in 1 BLISTER PACK | TABLET | 30 | 8 | |
| 70518-3423-2 | Lorazepam | 100 in 1 BOX | TABLET | 100 | 8 | |
| 70518-3423-3 | Lorazepam | 1 in 1 POUCH | TABLET | 1 | 8 | |
| 70518-3423-4 | Lorazepam | 100 in 1 BOX | TABLET | 100 | 8 | |
| 70518-3423-5 | Lorazepam | 1 in 1 POUCH | TABLET | 1 | 8 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals Inc. | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Redpharm Drug | 52614947-c96c-3361-e063-6394a90ae172 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | ANDA072927 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 6dfbe8be-168c-44e9-acfa-fa838b92d3b7 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 11372b3d-52c0-4694-8c88-4b72d3fda9d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 51119efa-c1a3-71f0-e063-6394a90a9e2a | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 5114810c-025f-6113-e063-6294a90af538 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | 462a13da-259a-40e7-bd5b-f7f42ae025b7 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0418ad09-3069-4381-9a8f-e41b234fdac6 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | A-S Medication Solutions | 8361519b-be1a-4542-a782-d7cdfa153e86 | 2026-01-24 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | a0a33933-f697-4d3b-ba99-8a995a4b6c6b | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| LORAZEPAM | LORAZEPAM | DIRECT RX | 4832f02d-289c-2fe6-e054-00144ff8d46c | 2026-01-08 | Warnings, Adverse reactions | 197900 O26FZP769L |
| LORAZEPAM | LORAZEPAM | Aurolife Pharma LLC | 5b851f67-309d-4ef3-8b4b-ade8908256ea | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | RedPharm Drug, Inc. | 891b2c10-942f-0e4d-e053-2995a90af028 | 2025-11-14 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | PharmPak, Inc. | b6e4d2c7-10c0-4d77-be7b-caa3d3b86997 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 1f79a5a1-0c40-45cf-8994-51f5ba3a5938 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0681c8db-ff09-4258-a5e0-76a26b0ea0af | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7afd9a59-3463-4eda-8cf3-ef90be05de3d | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA072927 197901 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 7999b9c3-6185-4e4e-a4c3-d5d33d6c31d6 | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 45e31a87-a8db-4dda-b94b-83535b62e8e2 | 2025-09-14 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 08a30230-fc95-9025-e063-6394a90ae21b | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | 197901 197900 197902 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.